NetworkNewsBreaks — SOBR Safe Inc. (NASDAQ: SOBR
Post# of 112
SOBRSafe (NASDAQ: SOBR), providers of next-generation transdermal alcohol detection solutions, announced that ALYST Health has selected the SOBRsafe(TM) technology to use in its concierge addiction treatment services. ALYST offers the first and only at-home addiction-treatment program accredited by the Joint Commission, which is the oldest and largest health care standards-setting body in the country. According to the announcement, ALYST has purchased a supply of SOBRsure(TM) alcohol-detection wristbands with plans to use them as a more flexible, humane fully at-home alcohol treatment program. ALYST company officials noted that conventional treatment centers and conventional monitoring methods don’t always provide privacy or personalized treatment. With the addition of SOBRsure to its program, ALYST can move the point of care from the treatment center to the comfort and privacy of a client’s home without sacrificing quality and while offering dignity and remote monitoring, which the company believes will empower recovery success. “We are honored to work with ALYST, a standard-bearer for behavioral health innovation,” said SOBRsafe chair and CEO Dave Gandini in the press release. “We both seek to optimize recovery outcomes by looking beyond the walls of traditional treatment.”
NOTE TO INVESTORS: The latest news and updates relating to SOBR are available in the company’s newsroom at http://nnw.fm/SOBR
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer